ID   ERAP1_RAT               Reviewed;         930 AA.
AC   Q9JJ22; Q9JJ23;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-MAR-2002, sequence version 2.
DT   24-JUL-2024, entry version 153.
DE   RecName: Full=Endoplasmic reticulum aminopeptidase 1;
DE            EC=3.4.11.-;
DE   AltName: Full=ARTS-1;
DE   AltName: Full=Adipocyte-derived leucine aminopeptidase;
DE            Short=A-LAP;
DE   AltName: Full=Aminopeptidase PILS;
DE   AltName: Full=Puromycin-insensitive leucyl-specific aminopeptidase;
DE            Short=PILS-AP;
GN   Name=Erap1; Synonyms=Appils, Arts1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Pineal gland;
RX   PubMed=10824104; DOI=10.1046/j.1432-1327.2000.01348.x;
RA   Schomburg L., Kollmus H., Friedrichsen S., Bauer K.;
RT   "Molecular characterization of a puromycin-insensitive leucyl-specific
RT   aminopeptidase, PILS-AP.";
RL   Eur. J. Biochem. 267:3198-3207(2000).
CC   -!- FUNCTION: Aminopeptidase that plays a central role in peptide trimming,
CC       a step required for the generation of most HLA class I-binding
CC       peptides. Peptide trimming is essential to customize longer precursor
CC       peptides to fit them to the correct length required for presentation on
CC       MHC class I molecules. Strongly prefers substrates 9-16 residues long.
CC       Rapidly degrades 13-mer to a 9-mer and then stops. Preferentially
CC       hydrolyzes the residue Leu and peptides with a hydrophobic C-terminus,
CC       while it has weak activity toward peptides with charged C-terminus. May
CC       play a role in the inactivation of peptide hormones. May be involved in
CC       the regulation of blood pressure through the inactivation of
CC       angiotensin II and/or the generation of bradykinin in the kidney (By
CC       similarity). {ECO:0000250}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Monomer. May also exist as a heterodimer; with ERAP2.
CC       Interacts with RBMX (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9JJ22-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9JJ22-2; Sequence=VSP_005451, VSP_005452;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10824104}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase M1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF148323; AAF73106.1; -; mRNA.
DR   EMBL; AF148324; AAF73107.1; -; mRNA.
DR   RefSeq; NP_110463.1; NM_030836.1.
DR   AlphaFoldDB; Q9JJ22; -.
DR   SMR; Q9JJ22; -.
DR   STRING; 10116.ENSRNOP00000013625; -.
DR   MEROPS; M01.018; -.
DR   GlyCosmos; Q9JJ22; 6 sites, No reported glycans.
DR   GlyGen; Q9JJ22; 6 sites.
DR   iPTMnet; Q9JJ22; -.
DR   PhosphoSitePlus; Q9JJ22; -.
DR   jPOST; Q9JJ22; -.
DR   PaxDb; 10116-ENSRNOP00000013625; -.
DR   PeptideAtlas; Q9JJ22; -.
DR   UCSC; RGD:708542; rat. [Q9JJ22-1]
DR   AGR; RGD:708542; -.
DR   RGD; 708542; Erap1.
DR   eggNOG; KOG1046; Eukaryota.
DR   InParanoid; Q9JJ22; -.
DR   OrthoDB; 3085317at2759; -.
DR   PhylomeDB; Q9JJ22; -.
DR   Reactome; R-RNO-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   PRO; PR:Q9JJ22; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0004177; F:aminopeptidase activity; IMP:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; ISO:RGD.
DR   GO; GO:0005138; F:interleukin-6 receptor binding; ISS:UniProtKB.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008235; F:metalloexopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; ISO:RGD.
DR   GO; GO:0042277; F:peptide binding; IBA:GO_Central.
DR   GO; GO:0005164; F:tumor necrosis factor receptor binding; IPI:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IMP:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0019882; P:antigen processing and presentation; TAS:RGD.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0043171; P:peptide catabolic process; IBA:GO_Central.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0030163; P:protein catabolic process; IMP:RGD.
DR   GO; GO:0006508; P:proteolysis; ISO:RGD.
DR   CDD; cd09601; M1_APN-Q_like; 1.
DR   Gene3D; 1.25.50.20; -; 1.
DR   Gene3D; 2.60.40.1910; -; 1.
DR   Gene3D; 1.10.390.10; Neutral Protease Domain 2; 1.
DR   Gene3D; 2.60.40.1730; tricorn interacting facor f3 domain; 1.
DR   InterPro; IPR045357; Aminopeptidase_N-like_N.
DR   InterPro; IPR042097; Aminopeptidase_N-like_N_sf.
DR   InterPro; IPR024571; ERAP1-like_C_dom.
DR   InterPro; IPR034016; M1_APN-typ.
DR   InterPro; IPR001930; Peptidase_M1.
DR   InterPro; IPR050344; Peptidase_M1_aminopeptidases.
DR   InterPro; IPR014782; Peptidase_M1_dom.
DR   InterPro; IPR027268; Peptidase_M4/M1_CTD_sf.
DR   PANTHER; PTHR11533:SF156; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; 1.
DR   PANTHER; PTHR11533; PROTEASE M1 ZINC METALLOPROTEASE; 1.
DR   Pfam; PF11838; ERAP1_C; 1.
DR   Pfam; PF01433; Peptidase_M1; 1.
DR   Pfam; PF17900; Peptidase_M1_N; 1.
DR   PRINTS; PR00756; ALADIPTASE.
DR   SUPFAM; SSF63737; Leukotriene A4 hydrolase N-terminal domain; 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; Alternative splicing; Aminopeptidase; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Hydrolase; Immunity; Membrane;
KW   Metal-binding; Metalloprotease; Protease; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix; Zinc.
FT   CHAIN           1..930
FT                   /note="Endoplasmic reticulum aminopeptidase 1"
FT                   /id="PRO_0000026753"
FT   TOPO_DOM        1..2
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        3..23
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        24..930
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        343
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         172
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         306..310
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         342
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         346
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         365
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10095"
FT   SITE            427
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        59
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        143
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        403
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        655
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        749
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        890
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        393..432
FT                   /evidence="ECO:0000250"
FT   DISULFID        725..732
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         883..884
FT                   /note="FF -> CM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10824104"
FT                   /id="VSP_005451"
FT   VAR_SEQ         885..930
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10824104"
FT                   /id="VSP_005452"
SQ   SEQUENCE   930 AA;  106419 MW;  928E7143CBD0EE7F CRC64;
     MPSLLSLVLT FLAVSSPSCC QNSDTASPKA SNGASFPWNN MRLPEYITPI HYDLMIHANL
     STLTFWGKTE VEITVSQPTS TIIMHSHQLQ ISKATLRRGA EEMLPEEPLK LMEYSAHEQV
     ALLTAQPLLA GSVYTVIITY AANLSENFHG FYKSTYRTQE GERRILAATQ FEPTAARMAF
     PCFDEPALKA SFSIKIKRDP RHLAISNMPL VKSVTVAEGL IEDHFDITVK MSTYLVAFII
     SDFKSVSKMT KSGVKVSVYA VPDKINQADY ALDAAVTLLE FYEDYFSIPY PLPKQDLAAI
     PDFQSGAMEN WGLTTYRESA LLYDKEKSSA SSKLGITMTV SHELAHQWFG NLVTMEWWND
     LWLNEGFAKF MEFVSVTVTH PELKVEEYFF GKCFNAMEVD ALNSSHPVST PVENPAQIRE
     MFDEVSYEKG ACILNMLRDY LSADTFKRGI VQYLQKYSYK NTKNEDLWNS MMHICPTDGT
     QTMDGFCSRN QHSSSTSHWR QEVIDIKSMM NTWTLQKGFP LITITVRGRN VHLKQEHYMK
     GSECFPETGS LWHVPLTFIT SKSDSVQRFL LKTKTDVIIL PEAVEWIKFN VGMNGYYIVH
     YGDDGWASLN GLLKEAHTTI SSNDRASLIN NAFQLVSIGK LSIEKALDLI LYLKNETEIM
     PIFQGLNELI PMYKLMEKRD MVEVETQFKD FLLRLLKDLI NKQTWTDEGS VSERMLRSQL
     LLLACVHRYQ LCVQRAERYF REWKASNGNM SLPIDVTLAV FAVGAQNTEG WDFLYSKYQS
     SLSSTEKSQI EFSLCISQDP EKLQWLLDQS FKGEIIKTQE FPHILTLIGR NPVGYPLAWK
     FLKENWNKIV QKFELGSSSI AHMVMGTTNQ FSTRARLEEV KGFFSSLKKN GSQLRCVQQT
     IETIEENIRW MDKNFDKIRL WLQKERQELL
//
